Steven Z. Pavletic

31.4k total citations · 3 hit papers
267 papers, 7.0k citations indexed

About

Steven Z. Pavletic is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Steven Z. Pavletic has authored 267 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Hematology, 70 papers in Immunology and 58 papers in Genetics. Recurrent topics in Steven Z. Pavletic's work include Hematopoietic Stem Cell Transplantation (174 papers), T-cell and B-cell Immunology (41 papers) and Acute Lymphoblastic Leukemia research (37 papers). Steven Z. Pavletic is often cited by papers focused on Hematopoietic Stem Cell Transplantation (174 papers), T-cell and B-cell Immunology (41 papers) and Acute Lymphoblastic Leukemia research (37 papers). Steven Z. Pavletic collaborates with scholars based in United States, Germany and Croatia. Steven Z. Pavletic's co-authors include Stephanie J. Lee, Georgia B. Vogelsang, Paul J. Martin, Madan Jagasia, Daniel Wolff, Mary E.D. Flowers, Daniel J. Weisdorf, Joseph Pidala, Daniel H. Fowler and Kristin Baird and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Steven Z. Pavletic

257 papers receiving 6.9k citations

Hit Papers

The Biology of Chronic Graft-versus-Host Disease: A Task ... 2015 2026 2018 2022 2016 2015 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
    2016 283 citations Kenneth R. Cooke, Leo Luznik et al. Biology of Blood and Marrow Transplantation profile →
  2. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
    2015 280 citations Stephanie J. Lee, Daniel Wolff et al. Biology of Blood and Marrow Transplantation profile →
  3. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
    2018 266 citations Stephanie J. Lee, Daniel Wolff et al. Bone Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Z. Pavletic United States 45 4.8k 2.0k 1.4k 1.3k 1.1k 267 7.0k
Madan Jagasia United States 43 5.1k 1.1× 1.9k 1.0× 1.6k 1.1× 1.6k 1.2× 1.3k 1.1× 251 7.2k
Hildegard Greinix Austria 47 5.6k 1.2× 2.6k 1.3× 1.9k 1.3× 1.2k 0.9× 1.2k 1.0× 244 8.9k
Karen K. Ballen United States 45 5.8k 1.2× 1.9k 1.0× 2.1k 1.5× 1.8k 1.3× 1.9k 1.7× 234 8.1k
Régis Peffault de Latour France 51 4.5k 0.9× 3.7k 1.9× 1.8k 1.3× 752 0.6× 1.5k 1.3× 384 8.6k
Marcelo C. Pasquini United States 46 5.3k 1.1× 1.7k 0.8× 2.3k 1.6× 1.6k 1.2× 919 0.8× 246 7.6k
Christina Peters Austria 48 4.1k 0.8× 1.2k 0.6× 2.1k 1.5× 2.2k 1.6× 1.1k 0.9× 242 8.2k
Christopher Bredeson Canada 46 4.5k 0.9× 1.0k 0.5× 1.9k 1.3× 1.6k 1.2× 1.3k 1.2× 170 6.7k
Linda J. Burns United States 46 3.8k 0.8× 2.8k 1.4× 3.2k 2.3× 1.2k 0.9× 1.0k 0.9× 197 7.7k
Scott D. Rowley United States 44 5.2k 1.1× 1.7k 0.9× 2.6k 1.8× 807 0.6× 1.6k 1.4× 168 8.0k
Judith Marsh United Kingdom 52 6.6k 1.4× 2.7k 1.3× 1.8k 1.3× 713 0.5× 2.0k 1.7× 210 9.1k

Countries citing papers authored by Steven Z. Pavletic

Since Specialization
Citations

This map shows the geographic impact of Steven Z. Pavletic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Z. Pavletic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Z. Pavletic more than expected).

Fields of papers citing papers by Steven Z. Pavletic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Z. Pavletic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Z. Pavletic. The network helps show where Steven Z. Pavletic may publish in the future.

Co-authorship network of co-authors of Steven Z. Pavletic

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Z. Pavletic. A scholar is included among the top collaborators of Steven Z. Pavletic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Z. Pavletic. Steven Z. Pavletic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoff, Fieke W., Eduard Schulz, Steven Z. Pavletic, & Alain Mina. (2025). Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance. Blood Reviews. 74. 101319–101319.
2.
Wolff, Daniel, Corey Cutler, Thomas Jaki, et al.. (2025). Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease. Transplantation and Cellular Therapy.
3.
Lee, Stephanie J., Corey Cutler, Steven Z. Pavletic, & Bruce R. Blazar. (2024). Belumosudil for Chronic Graft-Versus-Host Disease after 2 or More Prior Lines of Systemic Therapy: 3-Year Follow-up of the Rockstar Study. Transplantation and Cellular Therapy. 30(2). S262–S263. 2 indexed citations
4.
Holtzman, Noa G., Rachel B. Salit, Brian C. Shaffer, et al.. (2024). High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention. Blood Advances. 8(16). 4294–4310. 4 indexed citations
5.
Schulz, Eduard, Steven Z. Pavletic, & Alain Mina. (2024). Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges. Seminars in Hematology. 61(6). 420–430.
6.
McManus, Taylor, Noa G. Holtzman, Susan Vitale, et al.. (2024). Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease. SHILAP Revista de lepidopterología. 5(1). 100627–100627. 1 indexed citations
7.
Rosenstein, Rachel K., Jeremy J. Rose, Stephen R. Brooks, et al.. (2023). Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease. SHILAP Revista de lepidopterología. 4(2). 100246–100246. 2 indexed citations
8.
Holtzman, Noa G., Annie Im, Arlene Berman, et al.. (2023). Baricitinib for Refractory Chronic Graft-Versus-Host Disease (cGVHD): Results of a Phase 1/2 Study. Transplantation and Cellular Therapy. 29(2). S251–S252. 1 indexed citations
9.
Schulz, Eduard, Peter D. Aplan, Sylvie Freeman, & Steven Z. Pavletic. (2023). Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes. Blood Advances. 7(16). 4381–4394. 7 indexed citations
10.
Lee, Stephanie J., et al.. (2022). Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-Versus-Host Disease Studies. Transplantation and Cellular Therapy. 28(3). S317–S318.
11.
Assmann, Julian C., Don Farthing, Keita Saito, et al.. (2021). Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI. Blood. 137(1). 126–137. 25 indexed citations
12.
Cutler, Corey, Stephanie J. Lee, Sally Arai, et al.. (2021). Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213). Transplantation and Cellular Therapy. 27(3). S7–S8. 3 indexed citations
13.
Rosenstein, Rachel K., et al.. (2020). Quality of Life in Patients With Skin of Color and Chronic Graft-vs-Host Disease. JAMA Dermatology. 156(5). 589–589. 5 indexed citations
14.
Cooke, Kenneth R., Leo Luznik, Stefanie Sarantopoulos, et al.. (2016). The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(2). 211–234. 283 indexed citations breakdown →
15.
Steinberg, Seth M., Sri Harsha Tella, Jennifer L. Hsu, et al.. (2016). Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(8). 1517–1524. 11 indexed citations
16.
Salit, Rachel B., Daniel H. Fowler, Robert M. Dean, et al.. (2013). Host Lymphocyte Depletion as a Strategy to Facilitate Early Full Donor Chimerism after Reduced-Intensity Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(10). 1509–1513. 5 indexed citations
17.
Bishop, Michael, Edwin P. Alyea, Mitchell S. Cairo, et al.. (2011). National Cancer Institute’s First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee. Biology of Blood and Marrow Transplantation. 17(4). 443–454. 31 indexed citations
18.
Ryan, Mary, et al.. (2010). Acupuncture Treatment for Persistent Hiccups in Patients with Cancer. The Journal of Alternative and Complementary Medicine. 16(7). 811–816. 30 indexed citations
19.
Martin, Paul J. & Steven Z. Pavletic. (2008). Biology and Management of Chronic Graft-Versus-Host Disease. Cancer treatment and research. 144. 277–298. 8 indexed citations
20.
Pavletic, Steven Z., S J Lee, Gèrard Socié, & G. B. Vogelsang. (2006). Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplantation. 38(10). 645–651. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Madan Jagasia Breakdown of academic impact, for papers by Hildegard Greinix Breakdown of academic impact, for papers by Karen K. Ballen Breakdown of academic impact, for papers by Régis Peffault de Latour Breakdown of academic impact, for papers by Marcelo C. Pasquini Breakdown of academic impact, for papers by Christina Peters Breakdown of academic impact, for papers by Christopher Bredeson Breakdown of academic impact, for papers by Linda J. Burns Breakdown of academic impact, for papers by Scott D. Rowley Breakdown of academic impact, for papers by Judith Marsh
Rankless by CCL
2026